Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 351–375 of 566 matching trials (filtered from 7,816) · page 15 of 23, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Tau Networks in Psychotic Alzheimer's Disease NCT05847192 [18F]-PI2620 PET scan Runs in: United States · 1 site |
NA other |
RECRUITING | 91 | Northwell Health OTHER |
2026-04-08 |
|
Predicting Pre-dementia NCT07516119 Runs in: United States · 1 site |
NA other |
RECRUITING | 100 | Prevention Research Consortium Corp. OTHER |
2026-04-07 |
|
Selective PET Imaging of Astrocytes and Microglia in Alzheimer's Disease NCT05582200 Positron Emission Tomography (PET) using 11C-ER176 for TSPO and 18F... Runs in: United States · 1 site |
NA other |
RECRUITING | 71 | The Methodist Hospital Research Institute OTHER |
2026-04-06 |
|
Rifaximin SSD in Dementia Trial NCT06718686 Rifaximin SSD 40 mg IR tablet; Placebo Runs in: United States · 1 site |
PHASE1|PHASE2 other |
RECRUITING | 20 | Jasmohan Bajaj OTHER_GOV |
2026-04-03 |
|
Transcranial Magnetic Stimulation for MCI NCT05992831 Accelerated iTBS; Sham Comparator Runs in: United States · 1 site |
NA other |
RECRUITING | 60 | Medical University of South Carolina OTHER |
2026-04-02 |
|
BID LTM Digital Intervention in Aging NCT06916221 Long Term Memory; Worder Runs in: United States · 1 site |
NA other |
RECRUITING | 150 | University of California, San Francisco OTHER |
2026-04-02 |
|
Treatment of Chronic Anger and Aggression Following Military-Related Betrayal NCT06609330 Countering Chronic Anger and Aggression Related to Trauma and Trans... Runs in: United States · 1 site |
NA other |
RECRUITING | 40 | The University of Texas Health Science Center at San Antonio OTHER |
2026-04-01 |
|
BID WM Digital Intervention in Aging NCT06918704 Coherence; Worder Runs in: United States · 1 site |
NA other |
RECRUITING | 150 | University of California, San Francisco OTHER |
2026-04-01 |
|
Gamma Frequency Stimulation in Individuals With Down Syndrome NCT05196984 GENUS device (Active Settings); GENUS device (Sham Settings) Runs in: United States · 1 site |
NA other |
RECRUITING | 60 | Massachusetts Institute of Technology OTHER |
2026-03-31 |
|
Reducing Falls With Varenicline in Hypocholinergic Parkinson Disease NCT06679374 Placebo; Varenicline Runs in: United States · 1 site |
PHASE2 other |
RECRUITING | 102 | Vikas Kotagal OTHER |
2026-03-31 |
|
Chronic Treatment of Alzheimer's Disease by Gamma Light and Sound Therapy NCT05655195 GENUS device (Active Settings); GENUS device (sham settings) Runs in: United States · 1 site |
NA other |
RECRUITING | 60 | Massachusetts Institute of Technology OTHER |
2026-03-30 |
|
Connect-Home: Alzheimer's Disease and Related Dementias NCT06840587 Connect-Home ADRD Runs in: United States · 1 site |
NA other |
RECRUITING | 360 | University of North Carolina, Chapel Hill OTHER |
2026-03-30 |
|
Wake Forest Alzheimer's Disease Clinical Core NCT03140865 Runs in: United States · 1 site |
NA other |
RECRUITING | 850 | Wake Forest University Health Sciences OTHER |
2026-03-27 |
|
Inflammatory Challenge in Human Aggression. NCT06665074 Endotoxin (E. coli O:113, Reference Endotoxin); Saline (Placebo) Runs in: United States · 1 site |
PHASE2 other |
RECRUITING | 112 | Ohio State University OTHER |
2026-03-27 |
|
Early-Stage Partner in Care Living Alone Plus NCT06962111 Psychoeducational skills training intervention Runs in: United States · 1 site |
NA other |
RECRUITING | 70 | Arizona State University OTHER |
2026-03-27 |
|
Feasibility of A Smartphone Application Intervention in Community Settings: A Pretest-Posttest Pilot Study NCT07313540 utmbHealthyBrain Smartphone App Runs in: United States · 1 site |
NA other |
NOT_YET_RECRUITING | 40 | The University of Texas Medical Branch, Galveston OTHER |
2026-03-27 |
|
IMST for Dementia Risk Reduction NCT07349706 Inspiratory Muscle Strength Training High-Resistance; Inspiratory M... Runs in: United States · 1 site |
NA other |
RECRUITING | 30 | Florida State University OTHER |
2026-03-27 |
|
Brain Effects of Gamma Frequency Sensory Stimulation (40Hz Light, Sound and Other Devices) NCT07496918 GENUS; Tactile GENUS Runs in: United States · 1 site |
PHASE2 other |
RECRUITING | 150 | Massachusetts Institute of Technology OTHER |
2026-03-27 |
|
Targeted Transcranial Magnetic Stimulation to Improve Hippocampal-dependent Declarative Memory Abilities NCT03574207 Transcranial magnetic stimulation Runs in: United States · 1 site |
NA other |
RECRUITING | 80 | University of Nebraska OTHER |
2026-03-25 |
|
Enhancing Triadic Communication About Cognition for Older Adults With Alzheimer's Disease or Related Dementias Facing a Cancer Management Decision NCT06313853 COACH-Cog Runs in: United States · 1 site |
NA other |
RECRUITING | 300 | University of Rochester OTHER |
2026-03-24 |
|
Brain NAD in Alzheimer's Disease NCT07127510 Runs in: United States · 1 site |
NA other |
RECRUITING | 20 | Florida Atlantic University OTHER |
2026-03-24 |
|
The Pre-symptomatic Familial Amyotrophic Lateral Sclerosis (Pre-fALS) Study NCT00317616 Runs in: United States · 1 site |
NA other |
RECRUITING | 500 | University of Miami OTHER |
2026-03-20 |
|
Sense4Safety Intervention NCT07220668 Sense4Safety Runs in: United States · 1 site |
PHASE1|PHASE2 other |
RECRUITING | 200 | University of Pennsylvania OTHER |
2026-03-19 |
|
[18F]F-DOPA Imaging in Patients With Autonomic Failure NCT04246437 [18F]FDOPA; Carbidopa 200mg oral dose; Entacapone 400mg oral dose Runs in: United States · 1 site |
PHASE1 other |
RECRUITING | 40 | Daniel Claassen OTHER |
2026-03-16 |
|
Dementia Caregivers' Link to Assistance and Resources NCT06860035 Dementia Caregivers' Link to Assistance and Resources (DECLARE) Runs in: United States · 1 site |
NA other |
RECRUITING | 200 | Visiting Nurse Service of New York OTHER |
2026-03-13 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
Last updated
From the research library
The highest-scoring studies we hold on this subject, each summarized in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial